JNJ/AbbVie's Imbruvica + Venclexta show promising progression-free survival in late-stage blood cancer study
14 June 2021 - 6:26PM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
AbbVie (NYSE:ABBV)
Historical Stock Chart
From Apr 2024 to May 2024
AbbVie (NYSE:ABBV)
Historical Stock Chart
From May 2023 to May 2024